Evaluating the Impact of Lenalidomide on Bone Marrow Cancer Treatment: Monitoring White Blood Cell, Hemoglobin, and Platelet Levels

Evaluating the Impact of Lenalidomide on Bone Marrow Cancer Treatment: Monitoring White Blood Cell, Hemoglobin, and Platelet Levels

BACKGROUND: Lenalidomide (LEN), also known as Revlimid, is a drug used to treat multiple myeloma (MM), smoldering myeloma, and myelodysplastic syndromes. It is used as a first-line treatment for MM, along with dexamethasone. OBJECTIVE: To investigate the effects of LEN on the function of bone marrow...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiba Jumaa Hussein, Lara Ali Nazar, Hamsa Ghwamer Ghazi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Journal of Applied Hematology
Subjects:
bone marrow cancer
hemoglobin
lenalidomide
platelet levels
treatment monitoring
white blood cells
Online Access:https://journals.lww.com/10.4103/joah.joah_104_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items